Skip to main content
logo
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
3.970
-0.200 (-4.80%)
At close: Jul 29, 2026, 4:00 PM EDT
3.960
-0.010 (-0.25%)
After-hours: Jul 29, 2026, 5:55 PM EDT

Oramed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1621129793476545
Market Cap Growth
84.21%15.87%3.67%-80.42%-12.65%-21.55%
Enterprise Value
83.11-17.77-45.87-18.17320.47399.28
Last Close Price
3.972.852.422.3112.0314.28

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
1.621.90-16.50-46.70
Forward PE
-14.4014.4014.4014.4014.40
PS Ratio
-55.97-69.54176.08602.77
PB Ratio
0.720.560.660.573.143.27
P/TBV Ratio
0.700.610.680.573.093.27

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--8.89--13.56118.56441.69
EV/EBITDA Ratio
-1.193.641.17-32.35
EV/EBIT Ratio
-1.183.591.15-32.39
EV/FCF Ratio
-1.945.441.72--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.320.000.00
Debt / EBITDA Ratio
-----0.04
Net Debt / Equity Ratio
-0.27-0.65-0.97-0.67-1.02-0.88
Net Debt / EBITDA Ratio
4.618.6711.257.093.82-11.81
Net Debt / FCF Ratio
7.6114.1716.7910.475.4513.10
Asset Turnover
-0.0100.010.020.01
Quick Ratio
6.236.8424.973.0527.1019.85
Current Ratio
6.456.9825.193.0627.3420.08
Return on Equity (ROE)
50.21%37.10%-12.39%3.24%-23.77%12.29%
Return on Assets (ROA)
-5.25%-6.64%-8.16%-8.25%-23.98%11.08%
Return on Invested Capital (ROIC)
-10.78%-34.74%-54.52%-64.63%-474.43%56.36%
Return on Capital Employed (ROCE)
-6.06%-8.35%-8.07%-9.76%-24.88%11.71%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
65.72%52.63%-6.06%-2.14%
Dividend Yield
6.30%0.00%0.00%0.00%0.00%0.00%
Payout Ratio
9.72%0.00%0.00%0.00%0.00%0.00%
Buyback Yield / Dilution
-4.04%-3.84%-0.70%-4.02%-2.20%-34.04%
Total Shareholder Return
2.25%-3.84%-0.70%-4.02%-2.20%-34.04%
SEC Filings: 10-K · 10-Q